$300 Million is the total value of Decheng Capital Management III (Cayman), LLC's 26 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 80.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Sell | ACELYRIN INC(NSM) | $15,746,384 | -51.5% | 1,548,317 | -0.4% | 5.26% | -48.4% | |
ACET | Sell | Adicet Bio, Inc. | $274,275 | -77.7% | 200,201 | -60.4% | 0.09% | -76.1% |
NBSE | Exit | NeuBase Therapeutics, Inc. | $0 | – | -50,000 | -100.0% | -0.03% | – |
Exit | GeneDx Holdings Corp. | $0 | – | -103,604 | -100.0% | -0.19% | – | |
Exit | Apexigen, Inc. | $0 | – | -1,894,551 | -100.0% | -0.26% | – | |
Exit | AtriCure Inc. | $0 | – | -46,259 | -100.0% | -0.72% | – | |
SGEN | Exit | Seagen Inc. | $0 | – | -23,014 | -100.0% | -1.39% | – |
Exit | BeyondSpring Inc. | $0 | – | -4,958,143 | -100.0% | -1.84% | – | |
Exit | ROIVANT SCIENCES LTD | $0 | – | -1,459,700 | -100.0% | -4.62% | – | |
ALPPRNCL | Exit | Alpine Immune Sciences, Inc. | $0 | – | -6,708,288 | -100.0% | -21.63% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-12-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Illumnia, Inc. | 7 | Q3 2023 | 16.5% |
Cue Health Inc. | 7 | Q3 2023 | 17.8% |
Arcus BioSciences, Inc. | 7 | Q3 2023 | 8.4% |
10x Genomics, Inc. | 7 | Q3 2023 | 8.1% |
Pacific Biosciences of California, Inc. | 7 | Q3 2023 | 6.8% |
Equillium Inc. | 7 | Q3 2023 | 4.3% |
Aadi Bioscience, Inc. | 7 | Q3 2023 | 2.7% |
Adicet Bio, Inc. | 7 | Q3 2023 | 3.6% |
Aura Biosciences, Inc. | 7 | Q3 2023 | 6.1% |
Terns Pharmaceuticals, Inc. | 7 | Q3 2023 | 3.4% |
View Decheng Capital Management III (Cayman), LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
4 | 2024-01-22 |
13F-HR/A | 2023-12-12 |
13F-HR/A | 2023-11-29 |
13F-HR | 2023-11-13 |
13F-HR | 2023-07-28 |
13F-HR | 2023-05-10 |
13F-HR | 2023-02-09 |
13F-HR | 2022-11-08 |
4 | 2022-09-27 |
13F-HR | 2022-08-01 |
View Decheng Capital Management III (Cayman), LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.